Analysts have revised their fair value estimate for Akzo Nobel India downward from ₹3,853.50 to ₹3,653.50. They cite updated forecasts for profit margins and growth metrics as key factors in the reassessment.
What's in the News
- Final dividend of INR 30 per equity share for the financial year ended March 31, 2025, confirmed at the August 4, 2025 AGM (Key Developments)
- One-time special interim dividend of INR 156 per equity share for the financial year 2025-26 declared. Payment to be made within 30 days from August 4, 2025, with August 11, 2025 set as the record date (Key Developments)
- Board meeting held on August 4, 2025 discussed un-audited standalone and consolidated financial results for the quarter ended June 30, 2025, and potential interim dividend recommendations (Key Developments)
Valuation Changes
- Fair Value Estimate has decreased from ₹3,853.50 to ₹3,653.50, representing a downward revision of approximately 5%.
- Discount Rate has increased slightly from 13.45% to 13.52%.
- Revenue Growth outlook has increased marginally from 7.35% to 7.45%.
- Net Profit Margin projection has improved from 11.65% to 12.98%.
- Future Price/Earnings (P/E) ratio forecast has fallen from 43.39x to 36.87x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.